inclusion criteria: * willing and able to provide written informed consent, and * age \>= 18 years, and * sars-cov-2 positive pcr (nucleic acid) test within the preceding 7 days, and * not currently hospitalized, and * willing to abstain from any alcohol during the two week period in which disulfiram will be administered and during the two week period immediately after disulfiram administration. * both male and female subjects are eligible. females of childbearing potential must have a negative pregnancy test at screening and agree to use a double-barrier method of contraception throughout the study period.

inclusion criteria: * willing and able to provide written informed consent, and * age \>= 18 years, and * sars-cov-2 positive pcr (nucleic acid) test within the preceding 7 days, and * not currently hospitalized, and * willing to abstain from any alcohol during the two week period in which disulfiram will be administered and during the two week period immediately after disulfiram administration. * both male and female subjects are eligible. females of childbearing potential must have a negative pregnancy test at screening and agree to use a double-barrier method of contraception throughout the study period.

inclusion criteria: - willing and able to provide written informed consent, and - age >= 18 years, and - sars-cov-2 positive pcr (nucleic acid) test within the preceding 7 days, and - not currently hospitalized, and - willing to abstain from any alcohol during the two week period in which disulfiram will be administered and during the two week period immediately after disulfiram administration. - both male and female subjects are eligible. females of childbearing potential must have a negative pregnancy test at screening and agree to use a double-barrier method of contraception throughout the study period.

inclusion criteria: - willing and able to provide written informed consent, and - age >= 18 years, and - sars-cov-2 positive pcr (nucleic acid) test within the preceding 7 days, and - not currently hospitalized, and - willing to abstain from any alcohol during the two week period in which disulfiram will be administered and during the two week period immediately after disulfiram administration. - both male and female subjects are eligible. females of childbearing potential must have a negative pregnancy test at screening and agree to use a double-barrier method of contraception throughout the study period.